EUVIMEDSkopri EUVIMED
Crossref

Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes

Dominick J Lemas iD, Ruben Zapata iD, Isaac Loy, Aditya Mahadevan, Tony Wen iD, Rahma Mkuu, Adetola Louis-Jaques iD, Jaclyn Hall iD, Kylie K Harrall, Larissa Strath iD, Amy Sheer, Elizabeth Shenkman and 3 more

Obesity · 2026

DOI: 10.1002/oby.70221 ↗

At a glance

Journal article in Obesity, 2026. Written by Dominick J Lemas and 14 co-authors. Institution: Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA. Major MEDLINE topics: Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Diabetes Mellitus, Type 2, Pre-Eclampsia. Cited 4 times so far (Crossref); 42 references. Funded by: NIDDK NIH HHS, National Center for Advancing Translational Sciences of the National Institutes of Health, NIA NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are prescribed to women of reproductive age for obesity, type 2 diabetes, obstructive sleep apnea, and more. Data on pregnancy outcomes following prepregnancy exposure remain limited. We evaluated associations between prepregnancy GLP‐1RA exposure and maternal and neonatal outcomes among women with preexisting obesity and diabetes.

Methods

We conducted a retrospective cohort study using electronic health records data. Prepregnancy GLP‐1RA exposure was defined by prescription orders within 12 and 24 months prior to delivery. Propensity score matching was performed using maternal age, race and ethnicity, prepregnancy obesity status, diabetes type, chronic hypertension, insurance type, and rurality. Primary outcomes included preeclampsia (PE). Secondary outcomes included cesarean delivery, infant growth, gestational age at delivery, and neonatal intensive care unit length of stay.

Results

Among 31 exposed pregnancies, 29 were matched to unexposed controls. GLP‐1RA exposure was associated with higher prevalence of PE (12 months: p = 0.023; 24 months: p = 0.018). Cesarean delivery occurred more frequently among exposed pregnancies ( p < 0.05). No differences were observed in neonatal outcomes after matching.

Conclusions

Prepregnancy GLP‐1RA exposure was associated with higher prevalence of PE and cesarean delivery in this cohort. Larger studies are needed to confirm these findings and clarify underlying mechanisms.

Subjects

MeSH terms (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsObesityDiabetes Mellitus, Type 2Pre-EclampsiaHypertension, Pregnancy-InducedHypoglycemic AgentsHumansFemalePregnancyAdultRetrospective StudiesPregnancy OutcomeCesarean SectionRisk FactorsInfant, Newborn

Author keywords

GLP‐1 receptor agonistselectronic health recordsmaternal obesitypreconception carepreeclampsiahypertensive disorders of pregnancy

Substances

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Authors and institutions

  • Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Obstetrics and Gynecology, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Center for Research on Perinatal Outcomes, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Pain Research and Intervention Center of Excellence (PRICE), University of Florida, Gainesville, Florida, USA.
  • Claude D. Pepper Older Americans Independence Center (OAIC), University of Florida, Gainesville, Florida, USA.
  • Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID profiles: Dominick J Lemas, Ruben Zapata, Tony Wen, Adetola Louis-Jaques, Jaclyn Hall, Larissa Strath, Serena Guo, Michelle I Cardel

Funding

  • NIDDK NIH HHS
  • National Center for Advancing Translational Sciences of the National Institutes of Health
  • NIA NIH HHS
  • NCI NIH HHS
  • United States Association for the Study of Pain
  • Mayday Fund Clinical Translational Award
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences

Cite

APA

Lemas, D. J., Zapata, R., Loy, I., Mahadevan, A., Wen, T., Mkuu, R., Louis-Jaques, A., Hall, J., Harrall, K. K., Strath, L., Sheer, A., Shenkman, E., Guo, S., Cardel, M. I., & Smith, S. (2026). Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes. Obesity. https://doi.org/10.1002/oby.70221

Vancouver

Lemas DJ, Zapata R, Loy I, Mahadevan A, Wen T, Mkuu R, et al. Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes. Obesity. 2026. doi:10.1002/oby.70221

BibTeX
@article{Lemas2026,
  author = {Lemas, Dominick J and Zapata, Ruben and Loy, Isaac and Mahadevan, Aditya and Wen, Tony and Mkuu, Rahma and Louis-Jaques, Adetola and Hall, Jaclyn and Harrall, Kylie K and Strath, Larissa and Sheer, Amy and Shenkman, Elizabeth and Guo, Serena and Cardel, Michelle I and Smith, Steve},
  title = {Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70221}
}
Start for free →